Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 10, 2015

View Archived Issues

ValiRx acquires TRAC gene expression and biomarker technology

AstraZeneca supports Canadian National Access Project for Cancer Testing

Dermira releases phase IIb results of DRM-04

G1 Therapeutics completes Series B financing

Chronos Therapeutics establishes research collaboration with Kings College London

Adimab and Sanofi establish bispecific antibody collaboration

OnCore Biopharma describes license deal with NeuroVive in Tekmira Pharmaceutical merger document

Mitsubishi Tanabe Pharma updates activities of third quarter of fiscal 2014

Scientists identify new mutations amenable for therapeutic targeting in iCCA patients

Astellas Pharma reviews development highlights of third quarter of fiscal 2014

Sanofi presents highlights of fourth quarter 2014

Alkermes reports topline data from phase I study of ALKS-8700

Sodium channel modulators disclosed by Vertex Pharmaceuticals

Cadila Pharmaceuticals divulges agents for inflammation

FDA grants orphan drug status to tisagenlecleucel-T, copanlisib and ibrutinib for lymphomas

Cancer treatments receive FDA orphan drug status

Regulus Therapeutics reports topline data from RG-101 trial in HCV

Casi Pharmaceuticals reviews regulatory pathway for ENMD-2076

Epizyme patents EZH2 inhibitors

University of Texas discloses new sigma-receptor ligands

Boehringer Ingelheim Pharma presents new AMPK activators

Six-week ACH-3102/sofosbuvir regimen achieves 100% SVR12 in phase II study

STADApharm to launch Ebola rapid test

Roche acquires Signature Diagnostics

GSK and Theravance start second phase III trial of inhaled triple combination in COPD

LeafBio files IND application for Ebola virus therapeutic ZMapp

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...